Kole Roybal, PhD
Associate Professor
Microbiology and Immunology
School of Medicine

415-476-8289

In the Roybal Lab we harness the tools of synthetic and chemical biology to enhance the therapeutic potential of engineered immune cells. We take a comprehensive approach to cellular engineering by developing new synthetic receptors, signal transduction cascades, and cellular response programs to enhance the safety and effectiveness of adoptive cell therapies.

Show full bio (25 words) Hide full bio

We also study the logic of natural cellular signaling systems, and the underlying principles of cellular communication and collective cell behavior during an immune response.

Awards

Show all (6) Hide

  • NIH New Innovator Award, NIH - National Cancer Institute, 2018-2023
  • Award for Regenerative Medicine and Cell Therapy, Science Magazine & Sartorius, 2018
  • Chan Zuckerberg Biohub Investigator, Chan Zuckerberg Biohub, 2017
  • Member Researcher, Parker Institute for Cancer Immunotherapy, 2017
  • Postdoctoral Fellowship, Jane Coffin Childs Memorial Fund, 2014-2017
  • Ruth L. Kirschstein National Research Service Award, National Institutes of Health, 2007-2010

Education & Training

Show all (2) Hide

  • Ph.D. Immunology UT Southwestern Medical Center 2013
  • B.A. Biology Austin College 2005

Websites

Show all (5) Hide

Videos

Show all (1) Hide

Publications (60)

Top publication keywords:
Hematologic NeoplasmsNeoplasmsCell EngineeringT-LymphocytesSynthetic BiologyReceptors, NotchCell- and Tissue-Based TherapyAntigen-Presenting CellsLymphocyte ActivationReceptors, ArtificialActinsReceptors, Antigen, T-CellImmunotherapyActin Depolymerizing FactorsImmunotherapy, Adoptive

Show all (55 more) Hide